If you are:
Absolute Contraindication: SERIOUS RISKS POSSIBLE; MONTHLY PREGNANCY TEST REQUIRED BEFORE ADMINISTRATION
Absolute Contraindication: INSUFFICIENT DATA AVAIL; BASED ON DRUG PROPERTIES, ADV EFFECTS POSSIBLE
An adult over 60:
management or monitoring precaution: Cardiovascular-Start at lower doses and titrate upward more slowly in the elderly to minimize the risk for hypotension, dizziness and falls. Musculoskeletal-Increased risk of peripheral edema.
Giving Ambrisentan tablet to a child under 12:
management or monitoring precaution: No safety and efficacy data for pediatrics.